These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17552449)

  • 1. Effects of 4 classes of cardiovascular drugs on ventricular function in dogs with mitral regurgitation.
    Nakayama T; Nishijima Y; Miyamoto M; Hamlin RL
    J Vet Intern Med; 2007; 21(3):445-50. PubMed ID: 17552449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog.
    Perry GJ; Wei CC; Hankes GH; Dillon SR; Rynders P; Mukherjee R; Spinale FG; Dell'Italia LJ
    J Am Coll Cardiol; 2002 Apr; 39(8):1374-9. PubMed ID: 11955858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation.
    Nemoto S; Hamawaki M; De Freitas G; Carabello BA
    J Am Coll Cardiol; 2002 Jul; 40(1):149-54. PubMed ID: 12103269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of angiotensin-converting enzyme inhibitors of left atrial pressure in dogs with mitral valve regurgitation.
    Ishikawa T; Tanaka R; Suzuki S; Miyaishi Y; Akagi H; Iino Y; Fukushima R; Yamane Y
    J Vet Intern Med; 2010; 24(2):342-7. PubMed ID: 20102507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation between cardiomyocyte function and remodeling with beta-adrenergic receptor blockade in isolated canine mitral regurgitation.
    Pat B; Killingsworth C; Denney T; Zheng J; Powell P; Tillson M; Dillon AR; Dell'Italia LJ
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2321-7. PubMed ID: 18849331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pimobendan for mitral valve regurgitation in dogs.
    Kanno N; Kuse H; Kawasaki M; Hara A; Kano R; Sasaki Y
    J Vet Med Sci; 2007 Apr; 69(4):373-7. PubMed ID: 17485924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade.
    Hayashida W; Donckier J; Van Mechelen H; Charlier AA; Pouleur H
    Cardiovasc Res; 1997 Jan; 33(1):54-62. PubMed ID: 9059528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased sympathetic tone after short-term treatment with enalapril in dogs with mild chronic mitral valve disease.
    Chompoosan C; Buranakarl C; Chaiyabutr N; Chansaisakorn W
    Res Vet Sci; 2014 Apr; 96(2):347-54. PubMed ID: 24559801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular remodeling in preclinical experimental mitral regurgitation of dogs.
    Dillon AR; Dell'Italia LJ; Tillson M; Killingsworth C; Denney T; Hathcock J; Botzman L
    J Vet Cardiol; 2012 Mar; 14(1):73-92. PubMed ID: 22386719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of left ventricular Tei index (index of myocardial performance) in healthy dogs and dogs with mitral regurgitation.
    Teshima K; Asano K; Iwanaga K; Koie H; Uechi M; Kato Y; Kutara K; Kanno N; Seki M; Edamura K; Hasegawa A; Tanaka S
    J Vet Med Sci; 2007 Feb; 69(2):117-23. PubMed ID: 17339754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A translational assessment of preclinical versus clinical tools for the measurement of cardiac contractility: comparison of LV dP/dt(max) with echocardiography in telemetry implanted beagle dogs.
    Cools F; Dhuyvetter D; Vanlommel A; Janssens S; Borghys H; Geys H; Gallacher DJ
    J Pharmacol Toxicol Methods; 2014; 69(1):17-23. PubMed ID: 24140387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease.
    Bernay F; Bland JM; Häggström J; Baduel L; Combes B; Lopez A; Kaltsatos V
    J Vet Intern Med; 2010; 24(2):331-41. PubMed ID: 20102506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of milrinone for treating heart failure in dogs.
    Kittleson MD
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):905-18. PubMed ID: 1949499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of perindopril on left ventricular remodeling and aortic regurgitation in rats assessed by echocardiography.
    Murakami K; Mizushige K; Noma T; Kimura S; Abe Y; Matsuo H
    Angiology; 2000 Nov; 51(11):943-52. PubMed ID: 11103863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitation.
    Moesgaard SG; Pedersen LG; Teerlink T; Häggström J; Pedersen HD
    J Vet Intern Med; 2005; 19(5):712-9. PubMed ID: 16231716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
    Axelsson B; Häggmark S; Svenmarker S; Johansson G; Gupta A; Tydén H; Wouters P; Haney M
    J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):495-503. PubMed ID: 26837238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154.
    Al-Wathiqui MH; Shimshak TM; Brooks HL; Preuss KC; Wynsen JC; Gross GJ; Warltier DC
    Pharmacology; 1988; 36(4):217-27. PubMed ID: 3380877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty.
    Maniu CV; Patel JB; Reuter DG; Meyer DM; Edwards WD; Rihal CS; Redfield MM
    J Am Coll Cardiol; 2004 Oct; 44(8):1652-61. PubMed ID: 15489099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity.
    Harris KM; Aeppli DM; Carey CF
    Am Heart J; 2005 Nov; 150(5):1106. PubMed ID: 16291006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous mitral valve repair in the initial EVEREST cohort: evidence of reverse left ventricular remodeling.
    Foster E; Kwan D; Feldman T; Weissman NJ; Grayburn PA; Schwartz A; Rogers JH; Kar S; Rinaldi MJ; Fail PS; Hermiller J; Whitlow PL; Herrmann HC; Lim DS; Glower DD;
    Circ Cardiovasc Imaging; 2013 Jul; 6(4):522-30. PubMed ID: 23633132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.